FORT LAUDERDALE, Fla., June 28, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals Inc. (Pink Sheets: NOUV), a provider of quality all-natural dietary supplements, announced today that the Company’s Affiliate Sales Program is on track to officially launch next week.
Nouveau Life is currently developing an Affiliate Sales Program as part of its larger strategic marketing plan. The Nouveau Life Affiliate Sales Program will be based on the pay-for-performance model; affiliate partners will be paid a commission on each product sale they generate.
Nouveau Life has been diligent throughout the program’s development process to ensure that its Affiliate Sales Program is easy to use for program members. Affiliate Sales Program members will generate revenue by simply referring customers to the Nouveau Life website (www.nlpnaturals.com). Key elements of the Nouveau Life Affiliate Sales Program include:
- There are no Affiliate Sales Program membership fees.
- Nouveau Life will provide Affiliate Sales Program members with online marketing collateral including product banner advertising and email marketing text.
- Nouveau Life will stock and ship inventory for each individual order generated by an Affiliate Salesperson. Program members are not required or expected to purchase products at any time.
- Nouveau Life will process all payments through PayPal and will handle customer service issues.
- Affiliate Sales Program members will receive a commission on all orders generated from their referrals.
- High volume sales will be rewarded quarterly based on a set bonus commission structure.
- All of Nouveau Life’s products will be included in the Affiliate Sales Program.
Nouveau Life expects the Affiliate Sales Program to be complete next week. Those interested in participating in the program are encouraged to regularly check the Nouveau Life website at www.nlpnaturals.com for program updates and more information.
About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements - This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.
CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.